Dow Jones

40 211,72

0,00%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

INSM

Insmed (INSM)

Insmed Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
21/01/2009	14h00	PR Newswire (US)	Insmed and Premacure Announce European Orphan Designation for IPLEX(TM) in Retinopathy of Prematurity in Infants	NASDAQ:INSM
30/12/2008	14h34	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:INSM	Insmed Inc
23/12/2008	22h30	PR Newswire (US)	Insmed Announces that NASDAQ Extends Temporary Suspension of Minimum Bid Closing Price Rule	NASDAQ:INSM
25/11/2008	14h00	PR Newswire (US)	Insmed to Present at Sanford C. Bernstein Biosimilars Long View Conference	NASDAQ:INSM
18/11/2008	14h00	PR Newswire (US)	Insmed to Participate in Federal Trade Commission Roundtable on Follow-on Biologic Drugs: Framework for Competition and Continue	NASDAQ:INSM
11/11/2008	15h00	PR Newswire (US)	Beacon Equity Issues Technical Trade Alerts on Market Movers: ASTM, BRCD, DPTR, GERN, SWHC, INSM	NASDAQ:INSM	Insmed Inc
10/11/2008	14h00	PR Newswire (US)	Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs	NASDAQ:INSM
05/11/2008	23h05	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:INSM	Insmed Inc
05/11/2008	14h00	PR Newswire (US)	Insmed to Present at Upcoming Healthcare Conferences	NASDAQ:INSM
30/10/2008	21h18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSM	Insmed Inc
30/10/2008	12h00	PR Newswire (US)	Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008	NASDAQ:INSM
22/10/2008	14h00	PR Newswire (US)	NASDAQ's Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmed's Compliance Date to March 20, 2009	NASDAQ:INSM
21/10/2008	14h00	PR Newswire (US)	Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule	NASDAQ:INSM
20/10/2008	14h00	PR Newswire (US)	Insmed to Host Third Quarter 2008 Conference Call	NASDAQ:INSM
14/10/2008	22h30	PR Newswire (US)	Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)	NASDAQ:INSM
14/10/2008	14h05	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)	NASDAQ:INSM	Insmed Inc
14/10/2008	14h00	PR Newswire (US)	Insmed to Seek Shareholder Approval for Reverse Split	NASDAQ:INSM
23/09/2008	15h48	PR Newswire (US)	Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature	NASDAQ:INSM	Insmed Inc
15/09/2008	14h00	PR Newswire (US)	Insmed to Present at Biosimilars 2008 Conference	NASDAQ:INSM	Insmed Inc
04/09/2008	14h00	PR Newswire (US)	Insmed to Present at BioPharm Asia 2008 Conference	NASDAQ:INSM	Insmed Inc
03/09/2008	22h09	Edgar (US Regulatory)	Insmed Inc - Current report filing (8-K)	NASDAQ:INSM	Insmed Inc
03/09/2008	14h00	PR Newswire (US)	NASDAQ Hearing Panel Grants Insmed Request for Continued Listing on the NASDAQ Stock Market	NASDAQ:INSM	Insmed Inc
08/08/2008	22h06	Edgar (US Regulatory)	Insmed Inc - Quarterly Report (10-Q)	NASDAQ:INSM	Insmed Inc
08/08/2008	14h00	PR Newswire (US)	Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008	NASDAQ:INSM
28/07/2008	15h20	PR Newswire (US)	BeaconEquity.com Issues Technical Trade Alerts on Market Movers: EPCT, INSM, AMGN, CYBS, KONG, NCOC	NASDAQ:INSM	Insmed Inc
28/07/2008	14h00	PR Newswire (US)	Jim Miller, Ph.D. Joins Insmed Therapeutic Proteins as Vice President of Process Development	NASDAQ:INSM	Insmed Inc
25/07/2008	14h15	PR Newswire (US)	Insmed to Host Second Quarter 2008 Conference Call	NASDAQ:INSM	Insmed Inc
25/07/2008	14h00	PR Newswire (US)	Insmed CEO to Present at Drug Discovery & Development Conference	NASDAQ:INSM	Insmed Inc
22/07/2008	14h00	PR Newswire (US)	Insmed CEO to Present at Congressional Briefing on Follow-On Biologics	NASDAQ:INSM
21/07/2008	14h00	PR Newswire (US)	Insmed Provides Update on IPLEX(TM) Programs	NASDAQ:INSM